145 related articles for article (PubMed ID: 8532670)
1. Expression and secretion of a recombinant ricin immunotoxin from murine myeloma cells.
Krek CE; Ladino CA; Goldmacher VS; Blättler WA; Guild BC
Protein Eng; 1995 May; 8(5):481-9. PubMed ID: 8532670
[TBL] [Abstract][Full Text] [Related]
2. Expression of oligohistidine-tagged ricin B chain in Spodoptera frugiperda.
Afrin LB; Gulick H; Vesely J; Willingham M; Frankel AE
Bioconjug Chem; 1994; 5(6):539-46. PubMed ID: 7533004
[TBL] [Abstract][Full Text] [Related]
3. Ricin fusion toxin targeted to the human granulocyte-macrophage colony stimulating factor receptor is selectively toxic to acute myeloid leukemia cells.
Burbage C; Tagge EP; Harris B; Hall P; Fu T; Willingham MC; Frankel AE
Leuk Res; 1997 Jul; 21(7):681-90. PubMed ID: 9301690
[TBL] [Abstract][Full Text] [Related]
4. Double-site ricin B chain mutants retain galactose binding.
Frankel A; Tagge E; Chandler J; Burbage C; Willingham M
Protein Eng; 1996 Apr; 9(4):371-9. PubMed ID: 8738213
[TBL] [Abstract][Full Text] [Related]
5. Preproricin expressed in Nicotiana tabacum cells in vitro is fully processed and biologically active.
Tagge EP; Chandler J; Harris B; Czako M; Marton L; Willingham MC; Burbage C; Afrin L; Frankel AE
Protein Expr Purif; 1996 Aug; 8(1):109-18. PubMed ID: 8812841
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the galactose binding ability of recombinant ricin B chain.
Wales R; Richardson PT; Roberts LM; Woodland HR; Lord JM
J Biol Chem; 1991 Oct; 266(29):19172-9. PubMed ID: 1717462
[TBL] [Abstract][Full Text] [Related]
7. IL2 fused to lectin-deficient ricin is toxic to human leukemia cells expressing the IL2 receptor.
Frankel AE; Fu T; Burbage C; Chandler J; Willingham MC; Tagge EP
Leukemia; 1997 Jan; 11(1):22-30. PubMed ID: 9001414
[TBL] [Abstract][Full Text] [Related]
8. IL2-ricin fusion toxin is selectively cytotoxic in vitro to IL2 receptor-bearing tumor cells.
Frankel A; Tagge E; Chandler J; Burbage C; Hancock G; Vesely J; Willingham M
Bioconjug Chem; 1995; 6(6):666-72. PubMed ID: 8608178
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a ricin fusion toxin targeted to the interleukin-2 receptor.
Frankel AE; Burbage C; Fu T; Tagge E; Chandler J; Willingham M
Protein Eng; 1996 Oct; 9(10):913-9. PubMed ID: 8931131
[TBL] [Abstract][Full Text] [Related]
10. The effects of N-glycosylation on the lectin activity of recombinant ricin B chain.
Richardson PT; Hussain K; Woodland HR; Lord JM; Roberts LM
Carbohydr Res; 1991 Jun; 213():19-25. PubMed ID: 1718601
[TBL] [Abstract][Full Text] [Related]
11. Double-lectin site ricin B chain mutants expressed in insect cells have residual galactose binding: evidence for more than two lectin sites on the ricin toxin B chain.
Fu T; Burbage C; Tagge E; Chandler J; Willingham M; Frankel A
Bioconjug Chem; 1996; 7(6):651-8. PubMed ID: 8950484
[TBL] [Abstract][Full Text] [Related]
12. Phage display of ricin B chain and its single binding domains: system for screening galactose-binding mutants.
Swimmer C; Lehar SM; McCafferty J; Chiswell DJ; Blättler WA; Guild BC
Proc Natl Acad Sci U S A; 1992 May; 89(9):3756-60. PubMed ID: 1373889
[TBL] [Abstract][Full Text] [Related]
13. Expression of functional ricin B chain using the baculovirus system.
Ferrini JB; Martin M; Taupiac MP; Beaumelle B
Eur J Biochem; 1995 Nov; 233(3):772-7. PubMed ID: 8521841
[TBL] [Abstract][Full Text] [Related]
14. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
Wawrzynczak EJ; Watson GJ; Cumber AJ; Henry RV; Parnell GD; Rieber EP; Thorpe PE
Cancer Immunol Immunother; 1991; 32(5):289-95. PubMed ID: 1998970
[TBL] [Abstract][Full Text] [Related]
15. Expression of immunoglobulin heavy chain-ricin A chain fusions in mammalian cells.
Spooner RA; Allen DJ; Epenetos AA; Lord JM
Mol Immunol; 1994 Feb; 31(2):117-25. PubMed ID: 8309475
[TBL] [Abstract][Full Text] [Related]
16. Ricin toxin contains at least three galactose-binding sites located in B chain subdomains 1 alpha, 1 beta, and 2 gamma.
Frankel AE; Burbage C; Fu T; Tagge E; Chandler J; Willingham MC
Biochemistry; 1996 Nov; 35(47):14749-56. PubMed ID: 8942636
[TBL] [Abstract][Full Text] [Related]
17. Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas.
Kornfeld SB; Leonard JE; Mullen MD; Taetle R
Cancer Res; 1991 Mar; 51(6):1689-93. PubMed ID: 1998959
[TBL] [Abstract][Full Text] [Related]
18. Expression and functional properties of genetically engineered ricin B chain lacking galactose-binding activity.
Vitetta ES; Yen N
Biochim Biophys Acta; 1990 Jun; 1049(2):151-7. PubMed ID: 1694694
[TBL] [Abstract][Full Text] [Related]
19. Production and purification of immunologically active core protein p24 from HIV-1 fused to ricin toxin B subunit in E. coli.
Donayre-Torres AJ; Esquivel-Soto E; Gutiérrez-Xicoténcatl Mde L; Esquivel-Guadarrama FR; Gómez-Lim MA
Virol J; 2009 Feb; 6():17. PubMed ID: 19196485
[TBL] [Abstract][Full Text] [Related]
20. Recombinant ricin toxin A chain cytotoxicity against carcinoembryonic antigen expressing tumour cells mediated by a bispecific monoclonal antibody and its potentiation by ricin toxin B chain.
Embleton MJ; Charleston A; Robins RA; Pimm MV; Baldwin RW
Br J Cancer; 1991 May; 63(5):670-4. PubMed ID: 2039690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
